Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum.

A rapid, isocratic high-performance liquid chromatographic (HPLC) method is described for the determination of total homocysteine levels in human serum. Prior to reversed-phase HPLC analysis, the serum thiols were derivatized with SBD-F (ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate), a thiolspecific fluorogenic probe which is commercially available. Retention of SBD-homocysteine was sensitive to pH, and a mobile phase pH of 2.1 ensured baseline separation of serum thiols within 6 min. The method is simple, sensitive, reproducible (between-run coefficient of variation of 6.6%) and very suitable for routine determination of serum homocysteine levels in a clinical pathology laboratory.

[1]  R. Chu,et al.  The total serum homocysteine as an indicator of vitamin B12 and folate status. , 1988, American journal of clinical pathology.

[2]  D. Wilcken,et al.  Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. , 1988, Metabolism: clinical and experimental.

[3]  T. Toyo’oka,et al.  A novel fluorogenic reagent for thiols: ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate. , 1983, Analytical biochemistry.

[4]  D. Jacobson,et al.  Graves' disease with ophthalmopathy following radiotherapy for Hodgkin's disease. , 1984, The American journal of the medical sciences.

[5]  P. Ueland,et al.  Radioenzymic determination of homocysteine in plasma and urine. , 1985, Clinical chemistry.

[6]  J. Hardebo,et al.  Moderate Homocysteinemia - A Possible Risk Factor For Arteriosclerotic Cerebrovascular Disease , 1984, Stroke.

[7]  R. Green,et al.  Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection. , 1989, Analytical biochemistry.

[8]  K.,et al.  Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. , 1986, The Journal of clinical investigation.

[9]  D. Rabenstein,et al.  Determination of homocysteine, penicillamine, and their symmetrical and mixed disulfides by liquid chromatography with electrochemical detection. , 1989, Analytical biochemistry.

[10]  P. Ueland,et al.  Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. , 1989, The Journal of laboratory and clinical medicine.

[11]  T. Toyo’oka,et al.  High-performance liquid chromatography and fluorometric detection of biologically important thiols, derivatized with ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate (SBD-F). , 1983, Journal of chromatography.

[12]  B. Israelsson,et al.  Homocysteine and myocardial infarction. , 1988, Atherosclerosis.

[13]  J. Crouse.  Progress in coronary artery disease risk-factor research: what remains to be done? , 1984, Clinical chemistry.

[14]  F. Furukawa,et al.  Determination of thiols and disulfides in normal rat tissues and hamster pancreas treated with N-nitrosobis(2-oxopropyl)amine using 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole and ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate. , 1989, Biomedical chromatography : BMC.

[15]  P. Kamoun,et al.  Rapid determination of total homocysteine in plasma. , 1989, Clinical chemistry.

[16]  L. Taylor,et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.

[17]  B. Norrving,et al.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. , 1990, Atherosclerosis.

[18]  C. Hanes,et al.  Enzymic transpeptidation reactions involving γ-glutamyl peptides and α-amino-acyl peptides , 1952 .

[19]  P. Ueland,et al.  Fully automated fluorescence assay for determining total homocysteine in plasma. , 1989, Clinical chemistry.